Home Tags Indatuximab Ravtansine

Tag: Indatuximab Ravtansine

Featured Image: Cancer cell Courtesy: © 2018. Fotolia. Used with permission.

Indatuximab Ravtansine Shows Good Tolerability and Signs of Efficacy in Phase...

Results for Phase I/IIa study confirms that indatuximab ravtansine, also known as BT-062, an antibody-drug conjugate being developed by Biotets, offers good tolerability and...

ADC Market to Reach US$ 3 Billion by 2018

According to a report published by Research & Markets, one of the world's largest and most respected market research resource, the global market for Antibody-drug...

X